Not Yet RecruitingPhase 2/3

Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Controlled Trial

30 participantsStarted 2026-03-01

Plain-language summary

This study aims to clinically evaluate the efficacy of trigger points using active drug mix (Triamcinolone with lidocaine) on relief of myofascial pain of jaw muscle.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age more than or equal 18 years
✓. Both sexes
✓. Patients' willingness to follow instructions

Exclusion criteria

✕. Patients who will be using any medications to reduce the pain and/or have any effect on the skeletal muscle
✕. Clinical conditions such as pregnancy
✕. Medical problems that may interfere with the procedures such as bleeding disorders
✕. Cognitive impairment or exhibited inadequate cooperation
✕. Patients will be receiving physical therapy or wearing occlusal splint in the same period of the research

What they're measuring

current pain intensity

Timeframe: 1 week , 1 month , 3 months after treatment

Trial details

NCT IDNCT07445191

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-01

Contact for this trial

Ammar Ali Mudhsh Al-Hawbani Ammar Ali Mudhsh Al-Hawbani, bachelor's degree

0103052078 prof.hamidarefaee@gmail.com

View on ClinicalTrials.gov More TMJ Pain trials